Stock listing
NASDAQ:CGTX Cognition Therapeutics, Inc. Stock
Home listing (NASDAQ) of Cognition Therapeutics, Inc.
Follow Cognition Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:CGTX
$0.71 USD +0.01 (+1.6%)
Close on Nov 2, 2026
- Day range
- $0.699 – $0.74 USDNov 2, 2026
- Volume
- 346,459 sharesNov 2, 2026
- Market cap
- $67.48M USDAt the close on Nov 2, 2026 · price × 95.09M shares outstanding
- 52-week range
- $0.55 – $1.83 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $475,702 USDMedian day 398,300 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CGTX · Home | $0.71 USD | +0.011 (+1.6%) | 346,459 | $0.699 | $0.74 | $0.699 | $0.698 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:CGTX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.71 | +0.011 | +1.6% | $0.699 | $0.74 | $0.699 | 346,459 | |
| $0.698 | -0.041 | -5.6% | $0.722 | $0.722 | $0.645 | 557,208 | |
| $0.739 | -0.01 | -1.3% | $0.738 | $0.754 | $0.724 | 185,863 | |
| $0.749 | -0.01 | -1.3% | $0.768 | $0.784 | $0.735 | 350,885 | |
| $0.759 | +0.064 | +9.2% | $0.695 | $0.772 | $0.69 | 312,954 | |
| $0.695 | -0.024 | -3.3% | $0.724 | $0.73 | $0.69 | 289,854 | |
| $0.719 | +0.018 | +2.6% | $0.691 | $0.73 | $0.662 | 571,536 | |
| $0.701 | -0.046 | -6.2% | $0.80 | $0.818 | $0.70 | 1,017,357 | |
| $0.747 | +0.013 | +1.7% | $0.74 | $0.757 | $0.74 | 297,045 | |
| $0.734 | +0.006 | +0.9% | $0.73 | $0.758 | $0.726 | 461,532 | |
| $0.727 | -0.003 | -0.4% | $0.751 | $0.758 | $0.714 | 576,304 | |
| $0.73 | -0.003 | -0.4% | $0.76 | $0.787 | $0.713 | 429,200 | |
| $0.733 | -0.044 | -5.7% | $0.758 | $0.766 | $0.72 | 687,700 | |
| $0.777 | -0.025 | -3.1% | $0.80 | $0.815 | $0.77 | 520,800 | |
| $0.802 | -0.055 | -6.4% | $0.905 | $0.93 | $0.767 | 3,757,100 | |
| $0.857 | -0.02 | -2.3% | $0.87 | $0.898 | $0.833 | 413,300 | |
| $0.877 | -0.018 | -2.0% | $0.90 | $0.919 | $0.874 | 316,900 | |
| $0.895 | -0.042 | -4.5% | $0.948 | $0.948 | $0.894 | 452,700 | |
| $0.937 | -0.003 | -0.3% | $0.933 | $0.959 | $0.927 | 201,600 | |
| $0.94 | +0.002 | +0.2% | $0.94 | $0.96 | $0.926 | 329,500 | |
| $0.938 | +0.013 | +1.4% | $0.944 | $0.97 | $0.919 | 326,800 | |
| $0.925 | +0.034 | +3.8% | $0.921 | $0.93 | $0.901 | 300,100 | |
| $0.891 | -0.069 | -7.2% | $0.98 | $0.988 | $0.89 | 791,700 | |
| $0.96 | +0.006 | +0.6% | $0.98 | $0.984 | $0.96 | 386,100 | |
| $0.954 | +0.016 | +1.7% | $0.96 | $0.98 | $0.933 | 525,100 | |
| $0.938 | +0.001 | +0.1% | $0.929 | $0.96 | $0.92 | 200,200 | |
| $0.937 | -0.014 | -1.5% | $0.98 | $0.98 | $0.934 | 540,000 | |
| $0.951 | +0.001 | +0.1% | $0.967 | $0.967 | $0.93 | 266,400 | |
| $0.95 | -0.031 | -3.2% | $1.00 | $1.01 | $0.95 | 563,300 | |
| $0.981 | -0.019 | -1.9% | $1.03 | $1.03 | $0.981 | 329,500 | |
| $1.00 | -0.04 | -3.8% | $1.05 | $1.075 | $1.00 | 769,800 | |
| $1.04 | -0.02 | -1.9% | $1.06 | $1.07 | $1.04 | 336,200 | |
| $1.06 | +0.04 | +3.9% | $1.04 | $1.08 | $1.025 | 615,700 | |
| $1.02 | -0.015 | -1.4% | $1.04 | $1.07 | $1.01 | 531,700 | |
| $1.035 | +0.025 | +2.5% | $1.00 | $1.045 | $0.981 | 623,900 | |
| $1.01 | +0.027 | +2.7% | $0.987 | $1.03 | $0.97 | 229,000 | |
| $0.983 | +0.003 | +0.3% | $0.977 | $1.00 | $0.97 | 218,000 | |
| $0.98 | -0.01 | -1.0% | $0.99 | $1.005 | $0.97 | 293,500 | |
| $0.99 | -0.02 | -2.0% | $1.01 | $1.03 | $0.986 | 472,600 | |
| $1.01 | -0.02 | -1.9% | $1.02 | $1.04 | $1.00 | 261,200 | |
| $1.03 | -0.02 | -1.9% | $1.05 | $1.05 | $1.01 | 377,500 | |
| $1.05 | 0.00 | 0.0% | $1.05 | $1.06 | $1.02 | 261,200 | |
| $1.05 | +0.04 | +4.0% | $1.01 | $1.07 | $1.005 | 377,500 | |
| $1.01 | -0.02 | -1.9% | $1.02 | $1.025 | $0.982 | 335,900 | |
| $1.03 | +0.01 | +1.0% | $1.02 | $1.05 | $1.01 | 289,000 | |
| $1.02 | -0.04 | -3.8% | $1.07 | $1.07 | $1.02 | 347,400 | |
| $1.06 | +0.01 | +1.0% | $1.07 | $1.08 | $1.04 | 270,500 | |
| $1.05 | +0.02 | +1.9% | $1.03 | $1.06 | $0.994 | 466,200 | |
| $1.03 | +0.045 | +4.6% | $0.98 | $1.035 | $0.98 | 416,428 | |
| $0.985 | -0.011 | -1.2% | $0.99 | $1.00 | $0.96 | 249,742 | |
| $0.996 | +0.039 | +4.1% | $0.975 | $1.01 | $0.97 | 308,300 | |
| $0.957 | -0.022 | -2.2% | $0.985 | $0.987 | $0.93 | 303,400 | |
| $0.979 | -0.003 | -0.3% | $0.994 | $1.02 | $0.961 | 805,600 | |
| $0.982 | -0.038 | -3.7% | $1.01 | $1.03 | $0.982 | 379,800 | |
| $1.02 | +0.01 | +1.0% | $1.01 | $1.035 | $1.01 | 434,800 | |
| $1.01 | -0.03 | -2.9% | $1.04 | $1.05 | $1.00 | 509,500 | |
| $1.04 | 0.00 | 0.0% | $1.03 | $1.058 | $1.03 | 398,300 | |
| $1.04 | +0.02 | +2.0% | $1.03 | $1.06 | $1.00 | 821,300 | |
| $1.02 | -0.03 | -2.9% | $1.06 | $1.10 | $1.00 | 713,500 | |
| $1.05 | -0.03 | -2.8% | $1.05 | $1.09 | $1.03 | 1,032,400 | |
| $1.08 | -0.05 | -4.4% | $1.10 | $1.12 | $1.065 | 901,700 | |
| $1.13 | +0.07 | +6.6% | $1.10 | $1.15 | $1.08 | 1,049,900 | |
| $1.06 | +0.074 | +7.5% | $0.99 | $1.07 | $0.953 | 668,100 | |
| $0.986 | +0.094 | +10.5% | $0.902 | $1.02 | $0.896 | 733,800 | |
| $0.892 | +0.002 | +0.2% | $0.907 | $0.92 | $0.88 | 324,400 |
- Ticker
- NASDAQ:CGTX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 22, 2026
Cognition Therapeutics Announces Alignment with FDA on Pivotal Phase 3 Trial of Zervimesine (CT1812) in Dementia with Lewy Bodies
Latest earnings call · Mar 26, 2026
Cognition Therapeutics (NASDAQ:CGTX) Q4 2025 Earnings Call
Replay and transcript
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 19 slides
Calls
Upcoming
Cognition Therapeutics (NASDAQ:CGTX) Q3 2026 Earnings Call
Thu, Nov 05, 2026 · 8:30 AM ET
Register
Replays
Cognition Therapeutics (NASDAQ:CGTX) Q4 2025 Earnings Call
Thu, Mar 26, 2026 · 8:30 AM ET
Watch TranscriptCognition Therapeutics (NASDAQ:CGTX) Q4 2024 Earnings Call
Thu, Mar 20, 2025 · 8:00 AM ET
Watch TranscriptCognition Therapeutics (NASDAQ:CGTX) Q2 2024 Earnings Call
Thu, Aug 08, 2024 · 8:30 AM ET
Watch Transcript
Latest news
Cognition Therapeutics Announces Alignment with FDA on Pivotal Phase 3 Trial of Zervimesine (CT1812) in Dementia with Lewy Bodies
Oct 22, 2026
Closed $0.701 (-6.2%) on Oct 22, 2026
Cognition Therapeutics Announces Issuance of Composition of Matter Patent, Extending Protection for Zervimesine (CT1812) Through 2045
Oct 13, 2026
Closed $0.802 (-6.4%) on Oct 13, 2026
Cognition Therapeutics Schedules a Type C Meeting with FDA to Align on Endpoints for Phase 3 Trial of Zervimesine (CT1812) in DLB
Sep 29, 2026
Closed $0.954 (+1.7%) on Sep 29, 2026
Cognition Therapeutics to Present at H.C. Wainwright Global Investment Conference
Sep 8, 2026
Closed $1.01 (-1.9%) on Sep 8, 2026
Cognition Therapeutics Reports Financial Results for the Second Quarter 2026 and Provides Business Update
Aug 6, 2026
Closed $1.08 (-4.4%) on Aug 7, 2026
Cognition Therapeutics Participating in Fireside Chat at B. Riley Securities' Mind, Muscle & Vision Summit
Jul 13, 2026
Closed $1.02 (-6.4%) on Jul 13, 2026
Cognition Therapeutics Aligns on Key Aspects of Pivotal Study for Zervimesine (CT1812) in DLB Psychosis Following Receipt of FDA Meeting Minutes
Jun 24, 2026
Closed $1.02 (-38.2%) on Jun 24, 2026
Cognition Therapeutics Announces New Composition of Matter Patent, Extending Patent Protection for Lead Candidate, Zervimesine (CT1812) Through 2045
Jun 16, 2026
Closed $1.26 (+4.1%) on Jun 16, 2026
Cognition Therapeutics Participating in Upcoming Investor Conferences
Jun 1, 2026
Closed $1.25 (+5.9%) on Jun 1, 2026
Cognition Therapeutics Completes Meeting with FDA for Zervimesine (CT1812) in Dementia with Lewy Bodies with Psychosis
May 21, 2026
Closed $1.25 (-3.1%) on May 21, 2026
Decks
Investor Presentation (August 2026)
Investor deck · 19 slides · August 2026
Jefferies Global Healthcare Conference 2026
Conference · 17 slides · Jun 4, 2026
Investor Presentation (March 2026)
Investor deck · 31 slides · Mar 26, 2026
Investor Presentation (March 2026)
Investor deck · 31 slides · March 2026
Cognition Therapeutics, Inc. on 6ix
- News releases
- 25 in the last 12 months · 144 in all · newest Oct 22, 2026 · oldest 2021
- Calls
- 7 calls with a replay · 7 with a transcript · latest Mar 26, 2026
- Decks
- 31 decks · latest August 2026
Where Cognition Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CGTX · Home listing · This page | NASDAQ | United States | USD |
| BOATS:CGTX | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Cognition Therapeutics, Inc.